Iterum Therapeutics plc Annual Depreciation in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Iterum Therapeutics plc quarterly/annual Depreciation history and growth rate from 2016 to 2023.
  • Iterum Therapeutics plc Depreciation for the quarter ending March 31, 2024 was $7K, unchanged year-over-year.
  • Iterum Therapeutics plc annual Depreciation for 2023 was $31K, a 63.1% decline from 2022.
  • Iterum Therapeutics plc annual Depreciation for 2022 was $84K, a 78.5% decline from 2021.
  • Iterum Therapeutics plc annual Depreciation for 2021 was $391K, a 143% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $31K -$53K -63.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $84K -$307K -78.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $391K +$230K +143% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 $161K +$9K +5.92% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $152K +$16K +11.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-28
2018 $136K +$71K +109% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $65K +$65K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.